These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 21448107

  • 1. Treatment strategy in schizophrenia combined with eating disorder.
    Dadić-Hero E, Ružić K, Grahovac T, Valković T, Petranović D.
    Psychiatr Danub; 2011 Mar; 23(1):95-7. PubMed ID: 21448107
    [Abstract] [Full Text] [Related]

  • 2. Olanzapine treatment in anorexia nervosa: case report.
    Dadić-Hero E, Ruzić K, Pernar M, Kabalin M, Medved P.
    Psychiatr Danub; 2009 Mar; 21(1):122-5. PubMed ID: 19270636
    [Abstract] [Full Text] [Related]

  • 3. Antipsychotic treatment--side-effect and/or metabolic syndrome.
    Dadić-Hero E, Ružić K, Grahovac T, Palijan TZ, Petranović D, Sepić-Grahovac D.
    Psychiatr Danub; 2011 Mar; 23(1):98-100. PubMed ID: 21448108
    [Abstract] [Full Text] [Related]

  • 4. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D, Feve B, Frances Y, Corruble E, Lancon C, Chanson P, Maison P, Terra JL, Azorin JM, avec le soutien institutionnel du laboratoire Lilly.
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [Abstract] [Full Text] [Related]

  • 5. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M, Krupka-Matuszczyk I.
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [Abstract] [Full Text] [Related]

  • 6. Schizophrenia past clozapine: what works?
    Mustafa FA.
    J Clin Psychopharmacol; 2013 Feb; 33(1):63-8. PubMed ID: 23277242
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Antipsychotic-induced priapism and management challenges: a case report].
    Doufik J, Otheman Y, Khalili L, Ghanmi J, Ouanass A.
    Encephale; 2014 Dec; 40(6):518-21. PubMed ID: 24709224
    [Abstract] [Full Text] [Related]

  • 9. Quality of life in schizophrenia: a multicenter, randomized, naturalistic, controlled trial comparing olanzapine to first-generation antipsychotics.
    Silva de Lima M, de Jesus Mari J, Breier A, Maria Costa A, Pondé de Sena E, Hotopf M.
    J Clin Psychiatry; 2005 Jul; 66(7):831-8. PubMed ID: 16013897
    [Abstract] [Full Text] [Related]

  • 10. [Quality of life and social functioning in schizophrenic patients treated with olanzapine: 1 year follow-up naturalistic study].
    Mayoral F, Montejo AL, Bousoño M, González-Torres MA, Olivares JM, Ros S, Sanjuán J, Escobar R, Lara N.
    Actas Esp Psiquiatr; 2006 Jul; 34(1):7-15. PubMed ID: 16525900
    [Abstract] [Full Text] [Related]

  • 11. Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.
    Simpson GM, Glick ID, Weiden PJ, Romano SJ, Siu CO.
    Am J Psychiatry; 2004 Oct; 161(10):1837-47. PubMed ID: 15465981
    [Abstract] [Full Text] [Related]

  • 12. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
    Dossenbach M, Pecenak J, Szulc A, Irimia V, Anders M, Logozar-Perkovic D, Peciukaitiene D, Kotler M, Smulevich AB, West TM, Lowry AJ, Treuer T.
    J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
    [Abstract] [Full Text] [Related]

  • 13. Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial.
    Bissada H, Tasca GA, Barber AM, Bradwejn J.
    Am J Psychiatry; 2008 Oct; 165(10):1281-8. PubMed ID: 18558642
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
    Popović I, Ravanić D, Popović V, Vladejić S, Stanojević A, Stojanović M.
    Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
    [Abstract] [Full Text] [Related]

  • 16. Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial.
    Kryzhanovskaya L, Schulz SC, McDougle C, Frazier J, Dittmann R, Robertson-Plouch C, Bauer T, Xu W, Wang W, Carlson J, Tohen M.
    J Am Acad Child Adolesc Psychiatry; 2009 Jan; 48(1):60-70. PubMed ID: 19057413
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Switching among antipsychotics--focus on side effects.
    Ružić K, Dadić-Hero E, Grahovac T, Sabljić V, Kosec T, Knez R.
    Psychiatr Danub; 2011 Mar; 23(1):89-91. PubMed ID: 21448105
    [Abstract] [Full Text] [Related]

  • 20. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J, Marcus SC, West J, Countis L, Hall R, Regier DA, Olfson M.
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.